欧洲 · 通讯社与实时数据 · Reuters Technology
Lilly signs cancer research deal with Stipple Bio worth up to $5.9 billion
详细摘要
Drugmaker Eli Lilly has signed an oncology research collaboration and licensing agreement worth up to $5.9 billion with Stipple Bio, the privately held biotech firm said on…
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.reuters.com)
